pharmaceutical preparations, therapeutics, and substances for the treatment of metabolic diseases, microbiome-related conditions, and diseases and disorders associated with intestinal permeability; medical testing for diagnostic or treatment purposes in the field of conditions caused by or effected by the microbiome